1. Pink Sheet
  2. >>Geography

Almost 3,000 Patients Treated Under UK’s Early Access To Medicines Scheme

 
• By Leela Barham

Data provided to the Pink Sheet under freedom of information requests show the scale of patient access that has been delivered under the UK’s scheme for early access to products that have yet to receive a marketing authorization.

Sprint finish
The UK EAMS scheme speeds up patient access to new drugs • Source: Shutterstock

Under the UK’s Early Access to Medicines Scheme (EAMS), patients can get access to unapproved treatments for life-threatening or seriously debilitating conditions that have a clear unmet clinical need.

While the numbers of applications under the scheme are routinely published by the UK regulator, the Medicines and Healthcare products Regulatory Agency, the scale of patient access to EAMS medicines is not

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography